Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections

Clinical trial NCT04884308 · COMPLETED

Trial details

NCT number: NCT04884308
Sponsor: Johns Hopkins University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis Bronchiectasis Adult Non-Tuberculous Mycobacteria

Start date: 2021-04-28
Primary completion: 2023-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.